Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BIOLASE Inc    BIOL

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

BIOLASE Inc : BIOLASE Expects to Report Positive Cash Flow From Operations for Q4 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/22/2013 | 02:44pm CET
BIOLASE Expects to Continue to Generate Positive Cash Flow From Operations for 2013 Overall

IRVINE, CA -- (MARKETWIRE) -- 01/22/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that based on preliminary unaudited financial results, the Company expects to report that it generated positive cash flow from operations for Q4 2012.

"We are pleased with our preliminary unaudited financial results for Q4 2012. It is rewarding to see that our restructuring efforts over the past two years have enabled us to turn the Company around and that we are making significant progress toward achieving our financial goals," said Federico Pignatelli, Chairman and CEO. "The trends we are seeing in the adoption of dental lasers also give us confidence in achieving continued double-digit growth of our core dental franchise. Based on our current plans, we expect the Company will continue to generate positive cash flow from operations for the overall year ending December 31, 2013."

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers.

Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOLASE INC
12/02 INVESTOR INVESTIGATION OVER POTENTIA : Biol)
11/23 BIOLASE, INC : Change in Directors or Principal Officers (form 8-K)
11/22 BIOLASE : to Preview New Epic Pro™ Diode Laser at Greater New York Dental ..
11/14 MONDAY SECTOR LAGGARDS : Agriculture & Farm Products, Medical Instruments & Supp..
11/10 BIOLASE : Names Samuel B. Low, D.D.S., M.S., M.Ed., Vice President, Dental and C..
11/08 BIOLASE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
11/08 BIOLASE : reports 3Q loss
11/08 BIOLASE, INC : Results of Operations and Financial Condition, Financial Statemen..
11/08 BIOLASE : Reports 2016 Third Quarter and Nine-Month Results
11/01 BIOLASE : reg; to Host 2016 Third Quarter Financial Results Conference Call on N..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
11/02DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
11/08 BIOLASE's (BIOL) CEO Harold Flynn on Q3 2016 Results - Earnings Call Transcri..
11/08 Biolase misses by $0.02, beats on revenue
10/04 Midday Gainers / Losers
08/01 BIOLASE's (BIOL) CEO Harold Flynn on Q2 2016 Results - Earnings Call Transcri..
08/01 Biolase revenues up 16%; net loss improves in Q2
Advertisement
Financials ($)
More Financials
Chart BIOLASE INC
Duration : Period :
BIOLASE Inc Technical Analysis Chart | BIOL | US0909111082 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 2,00 $
Spread / Average Target 9,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Harold C. Flynn President, Chief Executive Officer & Director
Paul N. Clark Chairman
Richard R. Whipp Vice President-Operations
David C. Dreyer Chief Financial Officer & Senior Vice President
Dmitri Boutoussov Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOLASE INC116.38%123
THERMO FISHER SCIENTIF..-1.23%56 058
DANAHER CORPORATION9.60%53 482
BOSTON SCIENTIFIC CORP..10.95%27 710
PHILIPS15.05%26 897
INTUITIVE SURGICAL, IN..16.57%24 668
More Results